Abliva AB (publ)
NEVPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | 341.9% | -79.5% | – |
| Cost of Goods Sold | – | $0 | $0 | $0 |
| Gross Profit | – | -$0 | -$0 | -$0 |
| % Margin | – | -50,132.8% | -273,887.1% | -21,429.1% |
| R&D Expenses | – | $0 | $0 | $0 |
| G&A Expenses | – | $0 | $0 | $0 |
| SG&A Expenses | – | -$0 | $0 | $0 |
| Sales & Mktg Exp. | – | $0 | $0 | $0 |
| Other Operating Expenses | – | $0 | $0 | $0 |
| Operating Expenses | – | $0 | $0 | $0 |
| Operating Income | – | -$0 | -$0 | -$0 |
| % Margin | – | -70,473% | -268,354.8% | -81,776.2% |
| Other Income/Exp. Net | – | $0 | -$0 | -$0 |
| Pre-Tax Income | – | -$0 | -$0 | -$0 |
| Tax Expense | – | -$0 | $0 | $0 |
| Net Income | – | -$0 | -$0 | -$0 |
| % Margin | – | -69,714.6% | -274,077.4% | -81,786.8% |
| EPS | – | -0.09 | -0.11 | -0.33 |
| % Growth | – | 17.8% | 66.7% | – |
| EPS Diluted | – | -0.09 | -0.11 | -0.33 |
| Weighted Avg Shares Out | – | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | – | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $0 | $0 | $0 |
| EBITDA | – | -$0 | -$0 | -$0 |
| % Margin | – | -68,327% | -257,709.7% | -80,014.6% |